Professional Documents
Culture Documents
Dose Respons Relation Ship
Dose Respons Relation Ship
RELATIONSHIP
Prof.DR.H.J.MUKONO, dr.,MS.,MPH.
FAKULTY OF PUBLIC HEALTH
AIRLANGGA UNIVERSITY
SURABAYA
INDONESIA
Definitions
DOSE - amount of exposure to an agent.
RESPONSE - the reaction to the dose.
Reff:Frank.M.Balis (2007)
Dose & Drug Effects
• Pharmacodynamics what the drug does to the
body
• Effects of drug depends on dose
• In general...
as dose increases, effects increase
to a maximum
then effects decrease
Dose / Response
MACAM RESPON:
RESPON MEMATIKAN (LETHAL RESPONE)
RESPON TDK MEMATIKAN (NON-LETHAL RESPONE)
PENGGUNAAN HUBUNGAN
DOSIS RESPON
HARUS MEMPERHATIKAN BEBERAPA
ASUMSI DASAR :
80
60
% of Maximal
Effect
40
20
EC50
0
1 10 100 1000
[Drug] Reff. Megan Phillips (2006)
Dose-Response Curve
• How response changes as function of dose
– S-shaped curves
– Slope important
• Gradual
– dose small response change
• Steep
– dose large response change ~
Dose-response Relationship
• Weight of individual important
• Dose
–amount of drug per body weight
–mg/kg (milligrams/kilogram)
• Helps achieve equal blood concentrations
–often not tightly controlled in humans
Dose-response Relationship
• Drug effects are variable
– Probability statements
• Group dose-response curves
– % of population responding
– Response magnitude
• Different for each individual effect
• i.e., temperature, respiration, euphoria, etc. ~
Dose-Effect Parameters
POTENCY: The sensitivity of an organ or
tissue to the drug
Age Tissue/organ
Absorption sensitivity
Distribution (receptor status)
Elimination
Drug interactions Reff. R.Woodraw Setzer (US EPA, 2010)
Therapeutic Index
• Margin of safety
– % population responding
• Compare effective dose (ED50) to
– Lethal dose (LD50)
– Or toxic dose (TD50)
LD50
TI: 10mg/10mg = 1
100mg/10mg = 10
ED50
1000mg/10mg = 100 ~
Therapeutic Index: Side Effects
• Drug effects other than desired effects
–Drugs have multiple effects!
–TD50 : toxic dose
• TI for side effects
• Patient management
– Therapeutic drug monitoring
– Risk-benefit (therapeutic indices)
Evaluating the toxicity:
time factor
• Acute basis over a 14-d period,
• subchronic /subacute, 90-d period (daily given), additional
information gained, target organ, major toxic effects,
slower onset,
• chronic , life time of animal, post-mortem examination.
• Story on an antiviral drug for hepatitis- a delayed toxic
reaction occurred after administration was discontinued.
5/5 died suddenly, liver failure.
GENDER
• Ethanol consumption, first-pass metabolism, in female LDH
lower,
• Dinitrotoluene-induced hepatic tumor, higher incidence in
male: male glucuronide conjugation, biliary excretion,
hydrolyzed and reabsorption; urinary excretion
predominates in female better clearance;
• Chloroform-induced kidney damage, higher incidence in
male : androgen effect, testosterone-mediated, castration
diminished
AGE
• Age related change: 1. liver metabolism; 2. renal elimination; 3. body
composition
• Liver metabolism- less amount of drug metabolizing enzymes in
newborn infants.
– Therapeutic disorders
• (1) gray baby syndrome : inadequate glucuronidation of
chloramphenicol [chloramphenicol]
• (2) sulfonamide induced icterus: displacement of bilirubin from
plasma by sulfonamide;
In general, reduced binding of drug to plasma proteins in neonatal
period.
ALLERGY
•not follow dose-response
relationship
• e.g. chronic beryllium disease,
hypersensitivity lung disorder, exposure
to beryllium, lack of dose-response
relationship
THANKS VERYMUCH
FOR YOUR ATTENTION
TERIMA KASIH ATAS PERHATIANNYA